TABLE 6.
Comorbidities effect modification was not observed in female vs male subjects stratified by age at follow-up of 5-years.
| Comorbidity | Prevalence in S1 (%) | Prevalence in S2 (%) | p BDTT | ORcrude | ORMH | p MHT | CM | ||
| F | M | F | M | ||||||
| Anxiety | 18 | 13 | 21 | 20 | 0.54 | 1.33 | 1.23 | 0.43 | 8.35 |
| Hypertension | 15 | 18 | 7 | 7 | 0.75 | 0.92 | 0.86 | 0.64 | 6.5 |
| PTSD | 15 | 7 | 21 | 14 | 0.55 | 2.07 | 1.88 | 0.03 | 10 |
| High blood cholesterol | 11 | 15 | 0 | 4 | 0.11 | 0.7 | 0.54 | 0.12 | 30.5 |
| Panic attacks | 9 | 7 | 14 | 11 | 0.99 | 1.28 | 1.31 | 0.41 | -2.9 |
S1 represents stratum 1 (age at follow-up of 5 years > 50 years), S2 represents stratum 2 (age at follow-up of 5 years <= 50 years), OR1 and OR2 represent the odds ratio in S1 and S2 respectively, pBDTT represents the p-value obtained using the Breslow-Day-Tarone test (BDTT), ORcrude represents the crude (unadjusted) odds ratio, ORMH represents the adjusted (unconfounded) odds ratio computed using the Mantel-Haenszel formula, pMHT represents the p-value obtained using Mantel-Haenszel test (MHT) and CM represents the magnitude of confounding. F, female; M, male.